Skip to main content
Clinical Trials/CTRI/2016/02/006658
CTRI/2016/02/006658Not yet recruitingPhase 2

A study on impact of shodhana on Phyto-pharmacological properties and biological actions of Bhanga (Cannabis sativa Linn)leaf

IPGT and RA GAU Jamnagar0 sites40 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor
Enrollment
40

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1) Institutionally diagnosed patients of any type of cancer with pain and ECOG score upto 3.
  • 2) Patients willing to participate in trials.
  • 3) Patients of either sex aged between 18 â?? 70 years
  • 4) Patients undergoing any type of standard palliative treatment for cancer except for pain management.

Exclusion Criteria

  • 1) Systemic diseases like uncontrolled hypertension, uncontrolled diabetes, heart diseases, Lung diseases, hepatic and renal dysfunctions.
  • 2) Pregnancy and breast feeding women.
  • 3) Cancer patients with ECOG more than 3.
  • 4) Patients with inability to comprehend and complete the proposed course study as per instructions.

Investigators

Sponsor
IPGT and RA GAU Jamnagar

Similar Trials